Website
http://dataportal.arc.gov.au/NCGP/API/grants/FT120100697
Funding Status
Closed
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Funded Activity Summary
Light-responsive nanomaterials as nanomedicines: new approaches to treating macular degeneration, cancer and other critical unmet therapeutic needs. Nanotechnology is enabling new medicines for the treatment of important diseases such as cancer and macular degeneration. This project will investigate novel nanomaterials for the development of new highly effective medicines that can be controlled after administration, leading to reduced side effects and increased convenience for patients.Funded Activity Details
Start Date: 12-2012
End Date: 12-2016
Funding Scheme: ARC Future Fellowships
Funding Amount: $796,367.00
Funder: Australian Research Council
Research Topics
ANZSRC Field of Research (FoR)
Nanomedicine | Pharmacology and Pharmaceutical Sciences | Pharmaceutical Sciences | Colloid and Surface Chemistry
